AICentralResources
AI Tool Comparison

Comparing as AI Medical Research & Clinical Decision Support
Viz.ai vs Tempus AI

Compare features, pricing, pros & cons, and user ratings to decide which AI tool is best for your needs.

VS
Viz.ai official logo and brand icon

Viz.ai

Enterprise
Visit WebsiteFull Review
Tempus AI official logo and brand icon

Tempus AI

Enterprise
Visit WebsiteFull Review

Verdict by Category

AI content generation failed. Refresh the page to try again.
View Viz.ai View Tempus AI
Feature & Spec Matrix

Detailed Comparison24 Criteria

Complete side-by-side breakdown of specifications, capabilities, and feature parity

Swipe horizontally to compare features
Feature / Spec
Viz.ai
Viz.ai
Tempus AI
Tempus AI
Pricing Model
EnterpriseFDA-cleared AI clinical care coordination for neurovascular and cardiology — Institutional hospital and health system annual contracts
EnterpriseGenomic sequencing, clinical data analytics, and precision medicine AI — Custom institutional agreements for healthcare systems and life sciences
Starting Price
Custom / Contact Sales
Custom / Contact Sales
Free Plan & Trial Scope
Difference
No free plan or trial — enterprise hospital contracts via sales team
No free plan — genomic tests ordered by physicians; enterprise and biopharma data partnerships via sales
User Rating Score
Unrated
Unrated
Ideal Workflow / Use Case
Difference
Stroke centers, cardiac centers, and health systems needing AI-powered real-time detection and automated care team coordination for acute time-sensitive conditions
Oncologists, health systems, and biopharma companies needing AI-powered genomic profiling, precision medicine insights, clinical trial matching, and drug development data
Enterprise & Scalability
Difference
FDA cleared (12+ algorithms), CE marked, HIPAA compliant, HITRUST certified, SOC 2 Type II, CMS New Technology Add-on Payment (NTAP) recognized, HL7/FHIR integration, enterprise SLAs, multi-site deployment, and dedicated clinical implementation support
CLIA-certified genomics laboratory, CAP accredited, HIPAA compliant, SOC 2 Type II, de-identified patient data network of 7M+ records, EHR integration via HL7/FHIR, biopharma licensing agreements, and enterprise analytics platform with dedicated clinical account management
Core Categories
AI Healthcare ToolsAI Research & Education Tools
AI Healthcare ToolsAI Research & Education Tools
12 FDA-cleared AI algorithms for stroke, PE, aortic disease, and hypertrophic cardiomyopathy
Difference
Viz.ai Advantage
Not listed
Real-time CT scan analysis detecting LVO strokes in under 6 minutes
Supported
Supported
Automated mobile alerts to entire care team — neurologist, ED, interventionalist — simultaneously
Difference
Viz.ai Advantage
Not listed
HIPAA-compliant mobile care coordination platform with image viewing on smartphones
Supported
Supported
44% reduction in door-in-door-out (DIDO) time for LVO stroke patients
Supported
Supported
Medicare New Technology Add-on Payment (NTAP) recognized — CMS reimbursement pathway
Difference
Viz.ai Advantage
Not listed
Deployed across 1,000+ hospitals in the U.S. and Europe
Difference
Viz.ai Advantage
Not listed
Aortic disease module covering AAA, aortic dissection, and pulmonary embolism workflows
Difference
Viz.ai Advantage
Not listed
Integrated care coordination — patient referrals, pre-scan sharing, and transfer workflows
Difference
Viz.ai Advantage
Not listed
Backed by Google Ventures, Kleiner Perkins, and Tiger Global — $289M raised
Difference
Viz.ai Advantage
Not listed
Comprehensive genomic profiling — solid tumor (xT), germline (xG), RNA (xR), liquid biopsy (xF), and expression (xE) testing
Difference
Not listed
Tempus AI Advantage
Neuropsychiatry panel for pharmacogenomics and psychiatric medication response prediction
Difference
Not listed
Tempus AI Advantage
Cardiology ECG analysis AI for arrhythmia and cardiac condition detection
Difference
Not listed
Tempus AI Advantage
Biopharma data licensing and drug development partnerships with major pharma companies
Difference
Not listed
Tempus AI Advantage
Algos platform for population health analytics across health system patient cohorts
Difference
Not listed
Tempus AI Advantage
CLIA-certified lab with CAP accreditation for clinical-grade genomic report delivery
Difference
Not listed
Tempus AI Advantage
Publicly traded (NASDAQ: TEM) — founded 2015, 3,800+ employees, $8.79B total raised
Difference
Not listed
Tempus AI Advantage
Viz.ai icon

Viz.ai Pros & Cons

Pros

  • 12 FDA-cleared algorithms — broadest acute-condition AI portfolio in its class
  • Medicare NTAP reimbursement pathway — unique among AI imaging platforms
  • 44% reduction in DIDO times for stroke patients — peer-reviewed clinical evidence (ISC 2026)
  • 1,000+ hospital deployments across U.S. and Europe
  • Backed by Google Ventures, Kleiner Perkins, and Tiger Global — $289M raised
  • Simultaneous mobile alerts to full care team — no phone-tag delays
  • Expands from neurology to cardiology and pulmonology in one unified platform

Cons

  • Enterprise-only pricing — no self-serve or small clinic access
  • No published pricing — all contracts are custom
  • Primarily focused on acute/time-sensitive conditions — not general radiology reads
  • Requires integration with existing hospital imaging infrastructure
  • Implementation and onboarding take time for large multi-site systems
Tempus AI icon

Tempus AI Pros & Cons

Pros

  • Publicly traded (NASDAQ: TEM) — one of the most credible precision medicine AI companies
  • 7M+ de-identified patient records — one of the world's largest clinical-molecular datasets
  • Comprehensive genomic testing across 6 test types covering all major oncology applications
  • Tempus One AI provides real-time clinical insights at the point of care
  • TIME Trial dramatically improves clinical trial matching and enrollment rates
  • 3,800+ employees and $8.79B total capital raised since founding
  • Expanding beyond oncology into neuropsychiatry, cardiology, and infectious disease

Cons

  • Enterprise and institutional pricing — not accessible to individual clinicians or small practices
  • Focused primarily on oncology and genomics — not a general-purpose clinical AI tool
  • Genomic test turnaround requires laboratory processing time
  • Data platform access and licensing requires formal agreements
  • Some AI insights require institutional genomic data infrastructure to fully leverage
Head-to-Head Battle Cards

Popular Comparisons

Direct feature matrices, pricing breakdowns, and real-world benchmark duels

All AI Healthcare Tools comparisons
Viz.ai vs Aidoc Comparison Battle Card - Features, Pricing & Review in AI Healthcare Tools
Direct head-to-head AI tool comparison between Viz.ai and Aidoc in AI Healthcare Tools featuring side-by-side feature matrix, pricing tiers, and benchmark verdict.
AI Healthcare ToolsCompare
Tempus AI vs Insilico Medicine Comparison Battle Card - Features, Pricing & Review in AI Healthcare Tools
Direct head-to-head AI tool comparison between Tempus AI and Insilico Medicine in AI Healthcare Tools featuring side-by-side feature matrix, pricing tiers, and benchmark verdict.
AI Healthcare ToolsCompare
Tempus AI vs Atomwise Comparison Battle Card - Features, Pricing & Review in AI Healthcare Tools
Direct head-to-head AI tool comparison between Tempus AI and Atomwise in AI Healthcare Tools featuring side-by-side feature matrix, pricing tiers, and benchmark verdict.
AI Healthcare ToolsCompare
Tempus AI vs Nabla Comparison Battle Card - Features, Pricing & Review in AI Healthcare Tools
Direct head-to-head AI tool comparison between Tempus AI and Nabla in AI Healthcare Tools featuring side-by-side feature matrix, pricing tiers, and benchmark verdict.
AI Healthcare ToolsCompare